Oculomics and artificial intelligence in cardiovascular risk prediction: Ocular biomarker assessment and perspectives for precision medicine
International Health Sciences Review · 14.11.2026 · 2 (6)
DOI: 10.70164/ihsr.v2i6.274 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Health Sciences Review, online erschienen am 14.11.2026. Verfasst von Jessica Lara Anjos und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Oculomics uses ocular characteristics as potential biomarkers of systemic health. Combined with artificial intelligence (AI), it offers new opportunities for cardiovascular risk assessment. This study aims to analyze the applications of oculomics and AI in identifying ocular biomarkers associated with cardiovascular risk, highlighting their potential and limitations. This literature review examines retinal biomarkers, fundus photography, optical coherence tomography (OCT), optical coherence tomography angiography (OCTA), and AI-based computational models. The available evidence indicates that AI algorithms can identify retinal vascular and structural patterns associated with hypertension, diabetes mellitus, and cardiovascular conditions, supporting their potential use in risk stratification. However, detecting existing disease must be distinguished from predicting future cardiovascular events. Limited external validation, algorithmic interpretability, population representativeness, implementation costs, and data privacy remain sig nificant challenges. In conclusion, oculomics combined with AI represents a promising noninvasive approach to cardiovascular assessment and precision medicine. Nevertheless, further prospective studies and independent validation are required to establish its clinical utility and support broader implementation.
Zitieren
APA
Anjos, J. L., Anjos, C. N. D. S., Branco, G. D. M., Costa, I. D. O., Rossini, M. P., & Schneider, F. F. (2026). Oculomics and artificial intelligence in cardiovascular risk prediction: Ocular biomarker assessment and perspectives for precision medicine. International Health Sciences Review, 2(6). https://doi.org/10.70164/ihsr.v2i6.274
Vancouver
Anjos JL, Anjos CNDS, Branco GDM, Costa IDO, Rossini MP, Schneider FF. Oculomics and artificial intelligence in cardiovascular risk prediction: Ocular biomarker assessment and perspectives for precision medicine. International Health Sciences Review. 2026;2(6). doi:10.70164/ihsr.v2i6.274
BibTeX
@article{Anjos2026,
author = {Anjos, Jessica Lara and Anjos, Camila Nayara da Silva and Branco, Gabriela de Melo and Costa, Isaque de Oliveira and Rossini, Matheus Pedro and Schneider, Felipe Fraga},
title = {Oculomics and artificial intelligence in cardiovascular risk prediction: Ocular biomarker assessment and perspectives for precision medicine},
journal = {International Health Sciences Review},
year = {2026},
volume = {2},
number = {6},
doi = {10.70164/ihsr.v2i6.274}
}
EUVIMED